Salesforce, Inc. (NYSE:CRM) shares are trading higher today. The company disclosed an expanded global strategic partnership with IQVIA Holdings, Inc. (NYSE:IQV) to aid the development of its Life Sciences Cloud.

As part of the expanded partnership, IQVIA will license the Orchestrated Customer Engagement (OCE) CRM-related software to Salesforce.

The companies will collaborate to facilitate the development of Life Sciences Cloud for customer engagement, which is expected to be available in 2025. 

Also, IQVIA will continue to market the OCE CRM product and support its nearly 400 global OCE customers in 130+ countries through 2029. 

Frank Defesche, SVP and General Manager, Life Sciences at Salesforce, stated, “Our collaboration with IQVIA marks a pivotal moment for Salesforce Life Sciences Cloud innovation. It will transform the future of HCP engagement, bringing together our combined capabilities in CRM, AI, data, and the thought leadership of IQVIA, all on the trusted Einstein 1 Platform.” 

Also Read: Salesforce Spends $20M on Einstein Image Rights, Securing AI Brand Dominance and Guinness Record

“This collaboration will provide life science organizations with a single, intelligent end-to-end engagement platform to transform the customer experience to be orchestrated and personalized.”

Investors can gain exposure to the stock via REX FANG & Innovation Equity Premium Income ETF (NASDAQ:FEPI) and Fidelity Disruptive Technology ETF (NASDAQ:FDTX).

Also Read: Salesforce Selects Ironclad As Contract Lifecycle Management Platform, Promising Streamlined Processes And Enhanced Insights

Price Action: CRM shares are up 0.55% at $303.40 on the last check Tuesday.

Photo via Shutterstock